These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1232 related articles for article (PubMed ID: 33178330)

  • 21. Clinical approval of nanotechnology-based SARS-CoV-2 mRNA vaccines: impact on translational nanomedicine.
    Milane L; Amiji M
    Drug Deliv Transl Res; 2021 Aug; 11(4):1309-1315. PubMed ID: 33512669
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Advancements of Nanotechnology and Nanomaterials in Environmental and Human Protection for Combatting the COVID-19 During and Post-pandemic Era: A Comprehensive Scientific Review.
    Wibowo YG; Ramadan BS; Taher T; Khairurrijal K
    Biomed Mater Devices; 2023 May; ():1-24. PubMed ID: 37363141
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nanotechnology based solutions to combat zoonotic viruses with special attention to SARS, MERS, and COVID 19: Detection, protection and medication.
    Ramakrishnan SG; Robert B; Salim A; Ananthan P; Sivaramakrishnan M; Subramaniam S; Natesan S; Suresh R; Rajeshkumar G; Maran JP; Al-Dhabi NA; Karuppiah P; Valan Arasu M
    Microb Pathog; 2021 Oct; 159():105133. PubMed ID: 34390768
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nanotechnology-based Approaches and Investigational Therapeutics against COVID-19.
    Rahman MM; Ahmed M; Islam MT; Khan MR; Sultana S; Maeesa SK; Hasan S; Hossain MA; Ferdous KS; Mathew B; Rauf A; Uddin MS
    Curr Pharm Des; 2022; 28(12):948-968. PubMed ID: 34218774
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nanotechnology Interventions in the Management of COVID-19: Prevention, Diagnosis and Virus-Like Particle Vaccines.
    Balkrishna A; Arya V; Rohela A; Kumar A; Verma R; Kumar D; Nepovimova E; Kuca K; Thakur N; Thakur N; Kumar P
    Vaccines (Basel); 2021 Oct; 9(10):. PubMed ID: 34696237
    [TBL] [Abstract][Full Text] [Related]  

  • 26. How can nanotechnology help to combat COVID-19? Opportunities and urgent need.
    Campos EVR; Pereira AES; de Oliveira JL; Carvalho LB; Guilger-Casagrande M; de Lima R; Fraceto LF
    J Nanobiotechnology; 2020 Sep; 18(1):125. PubMed ID: 32891146
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antiviral Efficacies of FDA-Approved Drugs against SARS-CoV-2 Infection in Ferrets.
    Park SJ; Yu KM; Kim YI; Kim SM; Kim EH; Kim SG; Kim EJ; Casel MAB; Rollon R; Jang SG; Lee MH; Chang JH; Song MS; Jeong HW; Choi Y; Chen W; Shin WJ; Jung JU; Choi YK
    mBio; 2020 May; 11(3):. PubMed ID: 32444382
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nano-engineered tools in the diagnosis, therapeutics, prevention, and mitigation of SARS-CoV-2.
    Kamat S; Kumari M; Jayabaskaran C
    J Control Release; 2021 Oct; 338():813-836. PubMed ID: 34478750
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A Review of SARS-CoV-2 and the Ongoing Clinical Trials.
    Tu YF; Chien CS; Yarmishyn AA; Lin YY; Luo YH; Lin YT; Lai WY; Yang DM; Chou SJ; Yang YP; Wang ML; Chiou SH
    Int J Mol Sci; 2020 Apr; 21(7):. PubMed ID: 32290293
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nanotechnology Responses to COVID-19.
    Ruiz-Hitzky E; Darder M; Wicklein B; Ruiz-Garcia C; Martín-Sampedro R; Del Real G; Aranda P
    Adv Healthc Mater; 2020 Oct; 9(19):e2000979. PubMed ID: 32885616
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An evidence-based systematic review on emerging therapeutic and preventive strategies to treat novel coronavirus (SARS-CoV-2) during an outbreak scenario.
    Gudadappanavar AM; Benni J
    J Basic Clin Physiol Pharmacol; 2020 Sep; 31(6):. PubMed ID: 32924964
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Recent Progress in Nanotechnology for COVID-19 Prevention, Diagnostics and Treatment.
    Rasmi Y; Saloua KS; Nemati M; Choi JR
    Nanomaterials (Basel); 2021 Jul; 11(7):. PubMed ID: 34361174
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antiviral nanopharmaceuticals: Engineered surface interactions and virus-selective activity.
    Kolanthai E; Neal CJ; Kumar U; Fu Y; Seal S
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2022 Sep; 14(5):e1823. PubMed ID: 35697665
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A review on Promising vaccine development progress for COVID-19 disease.
    Belete TM
    Vacunas; 2020; 21(2):121-128. PubMed ID: 32837460
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Rapid Development and Early Success of Covid 19 Vaccines Have Raised Hopes for Accelerating the Cancer Treatment Mechanism.
    Amanpour S
    Arch Razi Inst; 2021 Mar; 76(1):1-6. PubMed ID: 33818952
    [TBL] [Abstract][Full Text] [Related]  

  • 36. COVID-19 vaccine development and a potential nanomaterial path forward.
    Shin MD; Shukla S; Chung YH; Beiss V; Chan SK; Ortega-Rivera OA; Wirth DM; Chen A; Sack M; Pokorski JK; Steinmetz NF
    Nat Nanotechnol; 2020 Aug; 15(8):646-655. PubMed ID: 32669664
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antiviral Activity of Nanomaterials against Coronaviruses.
    Muhammad W; Zhai Z; Gao C
    Macromol Biosci; 2020 Oct; 20(10):e2000196. PubMed ID: 32783352
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nanotechnology in the COVID-19 era: Carbon-based nanomaterials as a promising solution.
    Papi M; De Spirito M; Palmieri V
    Carbon N Y; 2023 Jun; 210():118058. PubMed ID: 37151958
    [TBL] [Abstract][Full Text] [Related]  

  • 39. On Facing the SARS-CoV-2 (COVID-19) with Combination of Nanomaterials and Medicine: Possible Strategies and First Challenges.
    Sivasankarapillai VS; Pillai AM; Rahdar A; Sobha AP; Das SS; Mitropoulos AC; Mokarrar MH; Kyzas GZ
    Nanomaterials (Basel); 2020 Apr; 10(5):. PubMed ID: 32354113
    [TBL] [Abstract][Full Text] [Related]  

  • 40. New insights from nanotechnology in SARS-CoV-2 detection, treatment strategy, and prevention.
    Solanki R; Shankar A; Modi U; Patel S
    Mater Today Chem; 2023 Apr; 29():101478. PubMed ID: 36950312
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 62.